College of Traditional Chinese Medicine, Shandong University of Traditional Chinese Medicine, Jinan, China.
The Second Affiliated Hospital of Shandong University of Traditional Chinese Medicine, Jinan, China.
Pain Res Manag. 2022 Apr 14;2022:7570533. doi: 10.1155/2022/7570533. eCollection 2022.
This meta-analysis aims to evaluate the effectiveness and safety of transcutaneous electrical acupoint stimulation (TEAS) in treating post-operative pain.
This meta-analysis was registered in PROSPERO (CRD42021286753). We searched PubMed, Embase, and the Cochrane Library for relevant randomized controlled trials (RCTs) about TEAS in treating postoperative pain that were published before November 2021. The primary outcome was visual analogue scale (VAS) within 24 h after surgery. The secondary outcomes included postoperative opioid analgesic drug consumption and the occurrence of adverse reactions within the postoperative 24-72 h. Adverse reactions included dizziness, nausea, and vomiting. Continuous variables were analyzed using mean difference (MDs) or standardized mean difference (SMDs) and 95% CIs. Relative risk (RR) and 95% CI were used for dichotomous data. The data were pooled and analyzed by RevMan 5.4 and STATA15.0 software.
Seventeen trials with 1375 participants were included. The current results suggested that application of TEAS showed obvious superiority in reducing VAS scores (SMD = -1.51, 95% CI = -2.20∼-0.82, I2 = 96%). Subgroup analysis was performed according to open surgery and minimally invasive surgery. VAS scores were decreased after surgery at 24 h (SMD = -0.84, 95% CI = -1.07∼-0.6, I2 = 96%; SMD = -0.88, 95% CI = -1.02∼-0.75, I2 = 96%). The incidence of postoperative dizziness and nausea and vomiting was significantly lower in the TEAS group within postoperative 24-72 h (RR = 0.48, 95% CI = 0.34∼0.68, I2 = 0%; RR = 0.66, 95% CI = 0.44∼1.01, I2 = 69%; and RR = 0.49, 95% CI = 0.24∼1.00, I2 = 51%). Postoperative opioid analgesics were also reduced in the TEAS group within 72 h after surgery (SMD = -2.10, 95% CI = -3.37∼-0.82, I2 = 96%).
TEAS can reduce postoperative pain as well as the incidence of dizziness, nausea, and vomiting and the number of analgesics used after surgery. TEAS is a reasonable modality to incorporate into a multimodal management approach for postoperative pain.
本荟萃分析旨在评估经皮穴位电刺激(TEAS)治疗术后疼痛的有效性和安全性。
本荟萃分析已在 PROSPERO(CRD42021286753)中注册。我们检索了 PubMed、Embase 和 Cochrane 图书馆中截至 2021 年 11 月发表的关于 TEAS 治疗术后疼痛的随机对照试验(RCT)。主要结局为术后 24 小时内的视觉模拟评分(VAS)。次要结局包括术后 24-72 小时内的阿片类药物术后镇痛药物消耗和不良反应的发生。不良反应包括头晕、恶心和呕吐。连续变量采用均数差(MDs)或标准化均数差(SMDs)和 95%置信区间(CI)进行分析。二分类数据采用相对危险度(RR)和 95%CI 进行分析。使用 RevMan 5.4 和 STATA15.0 软件对数据进行汇总和分析。
纳入了 17 项试验,共 1375 名参与者。当前结果表明,TEAS 的应用在降低 VAS 评分方面具有明显优势(SMD=-1.51,95%CI=-2.20∼-0.82,I2=96%)。根据开放性手术和微创手术进行了亚组分析。术后 24 小时 VAS 评分降低(SMD=-0.84,95%CI=-1.07∼-0.6,I2=96%;SMD=-0.88,95%CI=-1.02∼-0.75,I2=96%)。TEAS 组在术后 24-72 小时内术后头晕、恶心和呕吐的发生率显著降低(RR=0.48,95%CI=0.34∼0.68,I2=0%;RR=0.66,95%CI=0.44∼1.01,I2=69%;RR=0.49,95%CI=0.24∼1.00,I2=51%)。术后 72 小时内,TEAS 组阿片类药物的用量也减少(SMD=-2.10,95%CI=-3.37∼-0.82,I2=96%)。
TEAS 可减轻术后疼痛,降低头晕、恶心和呕吐的发生率以及术后镇痛药的使用量。TEAS 是一种合理的多模式管理术后疼痛的方法。